Hormone Replacement Therapy (HRT) in Indianapolis

Typical Hormone Replacement Therapy pricing in Indianapolis runs $100–$500 per month. The biggest variables are the provider's experience level and the specific device or product used. Newer technology and senior injectors price at the upper end. Pricing is quoted in US dollars (USD). Request a consultation from any of our listed Indianapolis clinics for a personalized quote.

ClinicCompass lists 2 verified Indianapolis-area clinics offering Hormone Replacement Therapy, concentrated in Indianapolis. Each listing includes real Google ratings so you can compare reputable options side by side before booking a consultation.

Among our 2 listed Indianapolis providers for Hormone Replacement Therapy, Revive RX currently holds the highest verified Google rating at 5★ across 316+ reviews (located in Indianapolis). "Best" is subjective. Compare 2–3 Indianapolis clinics before committing.

Results vary by patient, but most Indianapolis providers report 6–18 months of sustained benefit from a full Hormone Replacement Therapy series.

Most patients wait 24 hours before applying makeup to avoid irritation on freshly-treated skin.

Less than the marketing suggests. Bioidentical means the hormone molecule is the same as the one your body makes. FDA-approved estradiol patches, gels and sprays and micronized progesterone are exactly that, body-identical, precisely dosed and inexpensive. The word is mostly used to sell compounded creams, troches and pellets made by a compounding pharmacy from the same molecules, which are not FDA-approved. The 2020 National Academies review, commissioned by the FDA, found the evidence for compounded hormone therapy came mostly from anecdote and prescriber testimony, with limited oversight of quality, and called its widespread use a public health concern. If you want bioidentical hormones, ask for the approved ones first. Compounded versions make sense only when an approved product cannot be used, such as an allergy to an ingredient.

That fear comes from the 2002 Women's Health Initiative, which studied women averaging 63 years old on an older oral formulation and found a small, statistically non-significant increase in breast cancer diagnoses. Two decades of reanalysis showed the picture depends on age at start, type and route. For women who begin within 10 years of menopause, generally under 60, randomized data show lower all-cause mortality and fewer fractures. On that basis the FDA announced in November 2025, and approved in February 2026, the removal of the boxed warnings on cardiovascular disease, breast cancer and probable dementia from these products. Risks remain and are on the label: blood clots and stroke with oral estrogen (transdermal is lower), a small increase in breast cancer with long use of combined therapy, and endometrial cancer if estrogen is taken without a progestogen by a woman with a uterus. Women with a history of breast cancer, blood clots, stroke, or unexplained bleeding are generally not candidates.

FDA-approved estradiol patches or gel plus micronized progesterone cost $30 to $200 a month at a pharmacy, usually less with insurance, and the visits can be with any prescriber. Med spa and wellness clinic programs are cash: $100 to $300 a month for a monitored program using approved products, $150 to $500 a month for compounded cream regimens, and $350 to $800 per pellet insertion every three to four months (branded pellet programs such as BioTE sit at the top of that range), plus $150 to $400 in initial labs. If a clinic quotes only a pellet price, ask what the same program would cost with a patch.

Pellets are compounded estradiol or testosterone cylinders implanted under the skin of the hip every three to four months. They are convenient and popular in med spas because the visit is the product, and many women like them. The concerns are the ones the National Academies raised: the dose is not precisely controlled, it cannot be adjusted once implanted, hormone levels often run well above the range approved products deliver, and the product is not FDA-approved. The Menopause Society does not recommend them as first-line therapy. If you choose pellets, choose a clinic that measures your levels and does not re-implant early when symptoms return.

Sometimes. Low-dose testosterone can help low sexual desire in postmenopausal women, and that is the one use with reasonable evidence. There is no FDA-approved testosterone product for women, so it is prescribed off-label at a fraction of the male dose or compounded. Pellet programs often add testosterone by default and at doses that push levels far above the female range, which is where acne, hair growth and voice changes come from. Ask why it is being added and what level they are targeting.

Yes, and it is often when symptoms are worst. Perimenopausal women still ovulate irregularly, so regimens differ: cyclic progesterone, a low-dose birth control pill, or a patch with progesterone, depending on bleeding pattern and contraception needs. A prescriber who understands perimenopause will ask about your cycles first. Hot flashes, sleep disruption, mood changes and heavy or irregular bleeding all have hormone options; unexplained heavy bleeding needs an evaluation before anything is prescribed.

Estradiol patches, gels and tablets and micronized progesterone are Health Canada-approved prescription drugs, prescribed by family physicians, gynecologists and nurse practitioners, and usually covered by provincial or private plans. The Society of Obstetricians and Gynaecologists of Canada takes the same position as its American counterpart on timing and benefit. Compounded bioidentical creams and pellets are available through compounding pharmacies with a prescription and carry the same evidence caveats as in the US.